Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Mattern

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
The Hardest PartIsabel N Schellinger, Karin Mattern, Uwe Raaz
Cancer Research|February 28, 2002
WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cellsKatja Wosikowski, Karin Mattern, Isabel Schemainda, et al.
Frontiers in Cardiovascular Medicine|May 3, 2021
Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm DiseaseIsabel N Schellinger, Angelika R Dannert, Karin Mattern, et al.
Journal of the American Heart Association|February 13, 2024
Angiotensin Receptor-Neprilysin Inhibition (Sacubitril/Valsartan) Reduces Structural Arterial Stiffness in Middle-Aged MiceIsabel N Schellinger, Angelika Dannert, Annet Hoffmann, et al.
Cardiovascular Research|November 22, 2022
E-cigarette exposure augments murine abdominal aortic aneurysm development: role of Chil1Joscha Mulorz, Joshua M Spin, Pireyatharsheny Mulorz, et al.
Molecular Therapy. Nucleic Acids|March 26, 2021
MicroRNA miR-29b regulates diabetic aortic remodeling and stiffeningIsabel N Schellinger, Markus Wagenhäuser, Giriprakash Chodisetti, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
The Hardest PartIsabel N Schellinger, Karin Mattern, Uwe Raaz
Cancer Research|February 28, 2002
WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cellsKatja Wosikowski, Karin Mattern, Isabel Schemainda, et al.
Frontiers in Cardiovascular Medicine|May 3, 2021
Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm DiseaseIsabel N Schellinger, Angelika R Dannert, Karin Mattern, et al.
Journal of the American Heart Association|February 13, 2024
Angiotensin Receptor-Neprilysin Inhibition (Sacubitril/Valsartan) Reduces Structural Arterial Stiffness in Middle-Aged MiceIsabel N Schellinger, Angelika Dannert, Annet Hoffmann, et al.
Cardiovascular Research|November 22, 2022
E-cigarette exposure augments murine abdominal aortic aneurysm development: role of Chil1Joscha Mulorz, Joshua M Spin, Pireyatharsheny Mulorz, et al.
Molecular Therapy. Nucleic Acids|March 26, 2021
MicroRNA miR-29b regulates diabetic aortic remodeling and stiffeningIsabel N Schellinger, Markus Wagenhäuser, Giriprakash Chodisetti, et al.
Pageof 1